16 AUG 2017 Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas PNI Press Releases and News Clips Share: Previous Dr. Santosh Kesari Talks About Sustaining Brain Health Next Launch of PNI Medical Group Advances Care of Neurological and Cranial Disorders
16 AUG 2017 Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas PNI Press Releases and News Clips Share: Previous Dr. Santosh Kesari Talks About Sustaining Brain Health Next Launch of PNI Medical Group Advances Care of Neurological and Cranial Disorders
